EMERGENT BIOSOLUTIONS INC. COMMON STOCK
4.7400
07-5月-25 15:30:00
15 分の遅延
株式
-0.0500
-1.04%
本日の幅
4.7150 - 4.9100
ISIN
N/A
ソース
NYSE
-
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
06 9 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
10 8 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for Second Quarter 2022
01 8 2022 15:05:47 提供 Nasdaq GlobeNewswire
-
18 7 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
07 7 2022 15:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors
06 7 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
24 6 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
21 6 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
02 6 2022 07:20:49 提供 Nasdaq GlobeNewswire
-
16 5 2022 05:32:17 提供 Nasdaq GlobeNewswire
-
12 5 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results For First Quarter 2022
28 4 2022 15:05:36 提供 Nasdaq GlobeNewswire
-
08 4 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions Provides Corporate Governance Update
23 3 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
14 3 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
11 3 2022 05:34:09 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
24 2 2022 15:05:03 提供 Nasdaq GlobeNewswire
-
07 2 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Founder and Executive Chairman of Emergent BioSolutions Announces Retirement
14 1 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results
09 1 2022 13:00:00 提供 Nasdaq GlobeNewswire